TENX Message Board Post 9039096 | Tenax Therapeutics Inc.
home / stock / tenx / tenx message board
cls123
(investorshub)
Posted on: Mar/14/2023 04:30:05
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171437754
In and out for a 11% profit. I
News, Short Squeeze, Breakout and More Instantly...
-
Currently Enrolling Patients in Phase 3 LEVEL Study with 24 Investigative Sites Initiated Secured Global Development and Commercial Rights to Levosimendan for Treatment of PH-HFpEF Expanded Intellectual Property Estate for Levosimendan with Issuance of New U.S. Patent ...
-
Broadens IP protection for oral (TNX-103), IV, and subcutaneous use of levosimendan, and its active metabolites (OR1896 and OR1855), in PH-HFpEF ...